These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 1813716

  • 1. [Supplemental infection therapy with i.v. immunoglobulins (polyvalent IgG and Pseudomonas IgG)--results of an observational case study with 163 patients].
    Pilz G, Kääb S, Bujdoso O, Neumann R, Werdan K.
    Klin Wochenschr; 1991; 69 Suppl 26():178-84. PubMed ID: 1813716
    [Abstract] [Full Text] [Related]

  • 2. Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trials.
    Pilz G, Kääb S, Neeser G, Class I, Schweigart U, Brähler A, Bujdoso O, Neumann R, Werdan K.
    Infection; 1991; 19(4):216-27. PubMed ID: 1917032
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M, Fehnle K, Ostermann H, Kienast J, Cornely O, Salat C, Ubelacker R, Buchheidt D, Behre G, Hiddemann W, Schiel X.
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S, Riefolo A, Biscione R, Goretti E, Cattabriga I, Grillone G, Bacchi-Reggiani L, Pacini D.
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [Abstract] [Full Text] [Related]

  • 6. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.
    Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A, StreptIg Study Group.
    Clin Infect Dis; 2003 Aug 01; 37(3):333-40. PubMed ID: 12884156
    [Abstract] [Full Text] [Related]

  • 7. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V, Sharma M, Legac A, Gradiser M, Sefer S, Vucicević Z.
    Croat Med J; 2006 Jun 01; 47(3):385-97. PubMed ID: 16758516
    [Abstract] [Full Text] [Related]

  • 8. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB, Kirkpatrick AW, Delaney A.
    Crit Care Med; 2007 Dec 01; 35(12):2686-92. PubMed ID: 18074465
    [Abstract] [Full Text] [Related]

  • 9. The current management of septic shock.
    Russel JA.
    Minerva Med; 2008 Oct 01; 99(5):431-58. PubMed ID: 18971911
    [Abstract] [Full Text] [Related]

  • 10. [Early immunoglobulin therapy in high risk patients for infection after heart surgery].
    Pilz G, Kreuzer E, Kääb S, Appel R, Werdan K.
    Infusionsther Transfusionsmed; 1993 Apr 01; 20 Suppl 1():35-40; discussion 41. PubMed ID: 8499749
    [Abstract] [Full Text] [Related]

  • 11. Supplemental immune globulins in sepsis: a critical appraisal.
    Werdan K, Pilz G.
    Clin Exp Immunol; 1996 May 01; 104 Suppl 1():83-90. PubMed ID: 8625550
    [Abstract] [Full Text] [Related]

  • 12. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, Schaffartzik W.
    Crit Care Med; 1994 Nov 01; 22(11):1738-46. PubMed ID: 7956276
    [Abstract] [Full Text] [Related]

  • 13. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
    Arch Intern Med; 1994 Nov 14; 154(21):2484-91. PubMed ID: 7979845
    [Abstract] [Full Text] [Related]

  • 14. [Serum IgG concentrations and antibody titer of burn patients after preventive intravenous IgG substitution with a Pseudomonas immunoglobulin].
    Stuttmann R, Hartert M, Jahn M, Spilker G, Doehn M.
    Infusionsther Transfusionsmed; 1993 Apr 14; 20 Suppl 1():48-55. PubMed ID: 8499751
    [Abstract] [Full Text] [Related]

  • 15. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
    Pollack M, Huang AI, Prescott RK, Young LS, Hunter KW, Cruess DF, Tsai CM.
    J Clin Invest; 1983 Dec 14; 72(6):1874-81. PubMed ID: 6358257
    [Abstract] [Full Text] [Related]

  • 16. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Takala J, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan 14; 32(1):1-12. PubMed ID: 14707554
    [Abstract] [Full Text] [Related]

  • 17. [Use of pseudomonas immunoglobulin. Indications and results].
    Werdan K, Melnitzki S, Pilz G, Reuschel-Janetschek E.
    Anasth Intensivther Notfallmed; 1989 Jun 14; 24(3):153-61. PubMed ID: 2504071
    [Abstract] [Full Text] [Related]

  • 18. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
    Jacobs S, Price Evans DA, Tariq M, Al Omar NF.
    Crit Care Med; 2003 Jul 14; 31(7):1938-46. PubMed ID: 12847386
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial.
    Dellinger RP, Tomayko JF, Angus DC, Opal S, Cupo MA, McDermott S, Ducher A, Calandra T, Cohen J, Lipid Infusion and Patient Outcomes in Sepsis (LIPOS) Investigators.
    Crit Care Med; 2009 Nov 14; 37(11):2929-38. PubMed ID: 19770753
    [Abstract] [Full Text] [Related]

  • 20. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
    Albertson TE, Panacek EA, MacArthur RD, Johnson SB, Benjamin E, Matuschak GM, Zaloga G, Maki D, Silverstein J, Tobias JK, Haenftling K, Black G, Cowens JW, MAB-T88 Sepsis Study Group.
    Crit Care Med; 2003 Feb 14; 31(2):419-27. PubMed ID: 12576946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.